Improved survival in patients with transthyretin cardiac amyloidosis treated with TTR stabilizers
Journal of Cardiac Failure Aug 25, 2017
Rosenblum H, et al. – This study compared survival outcomes in patients with transthyretin (TTR) cardiac amyloidosis treated with or without stabilizer medications. In patients with TTR cardiac amyloidosis, treatment with TTR stabilizers was found to be related to an increased survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
